This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office division is for the delivery of VYVANSE 70 MG CAPSULE 100S, a pharmaceutical product. The contract, valued at $1,129.08, was awarded by the Defense Logistics Agency (DLA) on July 19, 2024 and has a completion date of July 22, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there is no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded...
This is a federal contract award to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, to provide VYVANSE 40 MG CAPSULE 100S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order with a Firm Fixed Price of $2,702.94 and an Ultimate Completion Date of August 6, 2024. The award is not associated with any set-aside program. AmerisourceBergen has been awarded numerous federal contracts and Indefinite Delivery Contracts...
This federal contract award is for the delivery of 100 units of VYVANSE 40 MG CAPSULE to the Defense Logistics Agency (DLA). The award was made to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, located in Conshohocken, Pennsylvania. The contract is a firm fixed price delivery order with a potential value of $3,972.72 and a completion date of February 22, 2024. No set-aside designation was used for this award....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of VYVANSE 70 MG CAPSULE 100S. The contract, valued at $4,448.45, is a Firm Fixed Price Delivery Order with a completion date of May 1, 2024. Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, will fulfill this order. The...
This federal contract award is for the delivery of VYVANSE 70 MG CAPSULE 100S, a prescription medication, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract has a ceiling value of $4,653.59 and is a firm fixed-price delivery order with an ultimate completion date of April 18, 2024. The contract is not set aside for any specific business type....
This federal contract award is for the delivery of VYVANSE CAPS 30MG pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The $8,569.54 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, on August 22, 2024 with a completion date of August 23, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which...
This federal contract award is for the delivery of VYVANSE 30 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The $4,203.89 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 4, 2020 with a completion date of November 5, 2020. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is a for-profit organization registered in the System for Award Management (SAM.gov). The contract does...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, is for the delivery of VYVANSE 40 MG CAPSULE 100S. The contract has a ceiling value of $5,968.31 and is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has no set-aside designation and has an ultimate completion date of September 24, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of VYVANSE 50 MG CAPSULE 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award is a Delivery Order valued at $4,941.93 and has an ultimate completion date of July 10, 2024. The contract is a Firm Fixed Price arrangement without any set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
This federal contract award is for the delivery of VYVANSE 70 MG CAPSULE 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,481.07 firm fixed-price contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 27, 2024 and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...